Early research (Phase 1)Study completedNCT01563471
What this trial is testing
Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers
Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors+1 more
Novo Nordisk A/S 39